Wellington Management Group
RCUS icon

Wellington Management Group’s Arcus Biosciences RCUS Stock Holding History

Wellington Management Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132M Buy
6,089,516
+905,007
+17% +$19.5M 0.02% 474
2025
Q4 		$124M Buy
5,184,509
+3,918,220
+309% +$79.9M 0.02% 502
2025
Q3 		$17.2M Buy
1,266,289
+330,268
+35% +$3.43M ﹤0.01% 1086
2025
Q2 		$7.62M Sell
936,021
-146,787
-14% -$1.25M ﹤0.01% 1284
2025
Q1 		$8.5M Buy
+1,082,808
New +$12.6M ﹤0.01% 1240
2019
Q4 		– Sell
-2,541,117
Closed -$23.1M – 2100
2019
Q3 		$23.1M Sell
2,541,117
-109,092
-4% -$877K 0.01% 924
2019
Q2 		$21.1M Sell
2,650,209
-1,607,497
-38% -$16.1M ﹤0.01% 994
2019
Q1 		$53.2M Sell
4,257,706
-25,628
-0.6% -$278K 0.01% 718
2018
Q4 		$46.1M Sell
4,283,334
-89,345
-2% -$1.04M 0.01% 731
2018
Q3 		$61M Sell
4,372,679
-25,183
-0.6% -$321K 0.01% 740
2018
Q2 		$53.8M Buy
4,397,862
+2,280,917
+108% +$35.8M 0.01% 765
2018
Q1 		$32.2M Buy
+2,116,945
New +$35.3M 0.01% 907

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group's RCUS Position: Q1 2026 in Review

Wellington Management Group increased its Arcus Biosciences (RCUS) stake by 17% in Q1 2026, buying an estimated $19.5M and bringing the position to 6,089,516 shares worth $132M. The position accounts for 0.02% of the portfolio, ranked #474.

Wellington Management Group first reported a position in RCUS in Q1 2018 and has held it in 12 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Wellington Management Group held 6,089,516 shares of Arcus Biosciences worth $132M as of Q1 2026.
  • Wellington Management Group bought 905,007 Arcus Biosciences shares in Q1 2026, an estimated $19.5M.
  • Arcus Biosciences made up 0.02% of Wellington Management Group's portfolio in Q1 2026, its #474 holding.
  • Wellington Management Group first reported a position in Arcus Biosciences in Q1 2018 and has held it in 12 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.